DIPYANONE. HCL
€70.00 – €27,800.00
DIPYANONE is a strong opioid analgesic drug, used for very severe pain in cases where other analgesics are unsuitable, for instance where morphine is indicated but cannot be used due to the patient being allergic to morphine…
This product is intended for research and forensic applications
DIPYANONE. HCL
Iupac name: 4,4-diphenyl-6-(pyrrolidin-1-yl)heptan-3-one
CAS NO: 60996-94-3
Chemical Formula: C23H29NO
Mol. Wt.: 335.49
Choose Option | 5g, 10g, 25g, 50g, 100g, 250g, 500g, 1000g |
---|
Related products
-
-
Rated 0 out of 5
Buy Diazepam Germany
Read moreDiazepam (Valium) is a drug of the benzodiazepine group, which is widely used in medical practice. Valium has a sedative, hypnotic, anti-anxiety, anticonvulsant, muscle relaxant and amnestic action. Enhances the effect of hypnotics, narco
-
Select options
BUTONITAZENE .HCL:
Formal Name :2-(2-(4-butoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine
Chemical Formula: C24H32N4O3
Molecular Weight: 424.55
BUTONITAZENE is an analgesic drug related to etonitazene, which was first reported in 1957,and has been shown to have approximately 50 times the potency of morphine by central routes of administration,but if used orally it has been shown to have approximately 5 times the potency of morphine.
Its effects are similar to other opioids like fent and her, including analgesia, euphoria, sleepiness. Adverse effects include vomiting, and respiratory depression that can potentially be fatal. Because of high dependency potential and dangerous adverse effects it has never been introduced in pharmacotherapy.
This product is intended for research and forensic applications.
-
Select options
Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed. A study of the drug’s effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate’s 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established: ED50 (mg/kg):123 Emylcamate also has a faster intra-parenteral onset then meprobamate, 3 minutes compared with 35
This product is intended for research and forensic applications
-
Select options
Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed. A study of the drug’s effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate’s 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established: ED50 (mg/kg):123 Emylcamate also has a faster intra-parenteral onset then meprobamate, 3 minutes compared with 35
This product is intended for research and forensic applications
Reviews
There are no reviews yet.